Gene expression profiling identifies new biological markers of neoplastic germ cells

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3091-3100

  Biermann, Katharina ^a,e   Heukamp, Lukas Carl ^a   Steger, Klaus ^b   Zhou, Hui ^a   Franke, Folker Ernst ^b   Guetgemann, Ines ^a   Sonnack, Violetta ^b   Brehm, Ralph ^b   Berg, Johannes ^c   Bastian, Patrick Jan ^a   Müller, Stefan Cajetan ^a   Wang Eckert, Lihua ^d   Schorle, Hubert ^a   Büttner, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Life and Brain Center   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Carcinoma; CIS; Embryonal; Genome; Germ; IGCNU; Neoplastic; Seminoma; Testicular

Indexed keywords

HISTONE H3; K RAS 2 PROTEIN; K RAS PROTEIN; PROTEIN NODAL; PROTEIN RAB39B; PROTEIN RALA; RAS PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GERM CELL TUMOR; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEMINOMA; TESTIS TUMOR;

ADULT; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 35349012697     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. McKiernan JM, Goluboff ET, Liberson GL, Golden R and Fisch H: Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162: 361-363, 1999.
2. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Ziegler H, Rahu M et al: Testicular cancer in nine northern European countries. Int J Cancer 59: 33-38, 1994.
3. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N and Rajpert-De Meyts E: Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS 111: 1-9, 2003.
4. Skakkebaek NE: Possible carcinoma in situ of the testis. Lancet 2: 516-517, 1972.
5. Skakkebaek NE: Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2: 157-170, 1978.
6. Oosterhuis JW and Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222, 2005.
7. Pauls K, Schorle H, Jeske W, Brehm R, Steger K, Wernert N, Buttner R and Zhou H: Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study. Hum Reproduction 21: 397-404, 2006.
8. Pauls K, Jager R, Weber S, Wardelmann E, Koch A, Buttner R and Schorle H: Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors. Int J Cancer 115: 470-477, 2005.
9. Looijenga LH and Oosterhuis JW: Pathogenesis of testicular germ cell tumours. Rev Reprod 4: 90-100, 1999.
10. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO and Thomson JA: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Nat Acad Sci USA 100: 13350-13355, 2003.
11. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ and Chaganti RS: Downregulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66: 820-827, 2006.
12. Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ and Chaganti RS: Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 24: 5101-5107, 2005.
13. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW and Lothe RA: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65: 5588-5598, 2005.
14. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E and Leffers H: Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64: 4736-4743, 2004.
15. Mostofi FK and Sesterhenn IA: Histological typing of testis tumours. Berlin: Springer, p. 132, 1998.
16. Walker SJ, Wang Y, Grant KA, Chan F and Hellmann GM: Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates. J Neurosci Methods 152: 179-189, 2005.
17. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Nat Acad Sci USA 98: 5116-5121, 2001.
18. Besser D: Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279: 45076-45084, 2004.
19. Zafarana G, Grygalewicz B, Gillis AJ, Vissers LE, van de Vliet W, van Gurp RJ, Stoop H, Debiec-Rychter M, Oosterhuis JW, van Kessel AG, Schoenmakers EF and Looijenga LH: 12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 22: 7695-7701, 2003.
20. Maecker HT, Todd SC and Levy S: The tetraspanin superfamily: molecular facilitators. FASEB J 11: 428-442, 1997.
21. Liu WM, Cao YJ, Yang YJ, Li J, Hu Z and Duan EK: Tetraspanin CD9 regulates invasion during mouse embryo implantation. J Mol Endocrinol 36: 121-130, 2006.
22. Oka M, Tagoku K, Russell TL, Nakano Y, Hamazaki T, Meyer EM, Yokota T and Terada N: CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 13: 1274-1281, 2002.
23. Sullivan KF: A solid foundation: functional specialization of centromeric chromatin. Current Opi Gen Dev 11: 182-188, 2001.
24. el-Naggar AK, Ro JY, McLemore D, Ayala AG and Batsakis JG: DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications. Am J Surg Pathol 16: 611-618, 1992.
25. Almstrup K, Ottesen AM, Sonne SB, Hoei-Hansen CE, Leffers H, Rajpert-De Meyts E and Skakkebaek NE: Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell Tissue Res 322: 159-165, 2005.
26. Takeda T, Go WY, Orlando RA and Farquhar MG: Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 11: 3219-3232, 2000.
27. Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM and Roskelley CD: Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 64: 5068-5073, 2004.
28. Ji P, Agrawal S, Diederichs S, Baumer N, Becker A, Cauvet T, Kowski S, Beger C, Welte K, Berdel WE, Serve H and Muller-Tidow C: Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells. Oncogene 24: 2739-2744, 2005.
29. Muller-Tidow C, Diederichs S, Schrader MG, Vogt U, Miller K, Berdel WE and Serve H: Cyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer letters 190: 89-95, 2003.